Get started
Author

Martin Lodén

Human heterochromatin proteins form large domains containing KRAB-ZNF genes
2006 · Maartje J. Vogel, Lars Guelen, et al. · Genome Research · 153
PDF
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
2002 · Martin Lodén, Maria Stighall, et al. · Oncogene · 107
Prospective Evaluation of Three Rapid Diagnostic Tests for Diagnosis of Human Leptospirosis
2013 · Marga G. A. Goris, Mariska M. G. Leeflang, et al. · PLoS neglected tropical diseases · 100
PDF
The impact of SF3B1 mutations in CLL on the DNA-damage response
2014 · G D te Raa, I A M Derks, et al. · Leukemia · 89
G1‐S transition defects occur in most breast cancers and predict outcome
1999 · Niels Hilmer Nielsen, Martin Lodén, et al. · Breast Cancer Research and Treatment · 68
RHD and RHCE variant and zygosity genotyping via multiplex ligation–dependent probe amplification
2012 · Lonneke Haer‐Wigman, Barbera Veldhuisen, et al. · Transfusion · 66
Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors
2012 · Sven Rottenberg, Marieke A. Vollebergh, et al. · Cancer Research · 52
PDF
High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1 -like Breast Cancer
2015 · Philip C. Schouten, Marieke A. Vollebergh, et al. · Molecular Cancer Therapeutics · 48
Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation
1999 · Martin Lodén, Niels Hilmer Nielsen, et al. · Oncogene · 45
Comprehensive genotyping for 18 blood group systems using a multiplex ligation‐dependent probe amplification assay shows a high degree of accuracy
2013 · Lonneke Haer‐Wigman, Yanli Ji, et al. · Transfusion · 39
Whole-genome views of chromatin structure
2005 · Martin Lodén, Bas van Steensel · Chromosome Research · 34
Long-term cultured IL-2-dependent T cell lines demonstrate p16INK4a overexpression, normal pRb/p53, and upregulation of cyclins E or D2
2000 · Jan K Siwicki, Ylva Hedberg, et al. · Experimental Gerontology · 18
Identification of Salmonella enterica Serovar Typhi Genotypes by Use of Rapid Multiplex Ligation-Dependent Probe Amplification
2013 · Duy Pham Thanh, Nga Tran Vu Thieu, et al. · Journal of Clinical Microbiology · 11
PDF
C-erbB2, p27 and G1/S aberrations in human primary breast cancer.
2003 · Martin Lodén, Frans Perris, et al. · PubMed · 9
Assessment of p53 and ATM Functionality in Chronic Lymphocytic Leukemia By Multiplex Ligation-Dependent Probe Amplification
2015 · Doreen te Raa, Perry Moerland, et al. · Blood · 1
Supplemental Figure Legends from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
Supplemental Tables from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
Supplementary Figure 3 from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
Supplemental Figure 1 from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
Supplementary Figure 2 from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
Supplementary Figure 2 from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
PDF
Supplemental Figure 1 from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
PDF
Supplementary Figure 3 from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
PDF
Data from High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
2023 · Philip C. Schouten, Marieke A. Vollebergh, et al.
Data from Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors
2023 · Sven Rottenberg, Marieke A. Vollebergh, et al.
Works count: 31
Citation count: 840
H-index: 12
I10-index: 13
Year
Topic
Type